Shares of Ranbaxy advanced by 4% to Rs177. According to reports, the company’s clinical trials for its malaria drug in final trial stage. The scrip touched an intra-day high of Rs180 and a low of Rs174 and recorded volumes of over 0.6mn shares on BSE.
"Visit Daily www.NorthPole77.com ,
Join profit making community...Today!"
